首页> 外文会议>International Conference on Chemistry and Material Science >Generating Two-Dimensional Repertoire of siRNA Linc-ROR and siRNA mRNA ARF6 from the lincRNA-RoR/miR-145/ARF6 expression Pathway that involved in the progression of Triple Negative Breast Cancer
【24h】

Generating Two-Dimensional Repertoire of siRNA Linc-ROR and siRNA mRNA ARF6 from the lincRNA-RoR/miR-145/ARF6 expression Pathway that involved in the progression of Triple Negative Breast Cancer

机译:从Lincrna-ROR / miR-145 / ARF6表达途径产生三维曲线和siRNA mRNA ARF6的二维曲目,参与三重阴性乳腺癌进展

获取原文

摘要

The research for finding the cure for breast cancer is currently entering the interesting phase of the transcriptomics based method. With the application of Next Generation Sequencing (NGS), molecular information on breast cancer could be gathered. Thus, both in silico and wet lab research has determined that the role of lincRNA-RoR/miR-145/ARF6 expression Pathway could not be ignored as one of the cardinal starting points for Triple-Negative Breast Cancer (TNBC). As the most hazardous type of breast cancer, TNBC should be treated wim the most advanced approach that available in the scientific community. Bioinformatics approach has found the possible siRNA-based drug candidates for TNBC. It was found that siRNA that interfere with lincRNA-ROR and mRNA ARF6 could be a feasible opportunity as the drug candidate for TNBC. However, this claim should be validated with more thorough thermodynamics and kinetics computational approach as the comprehensive way to comprehend their molecular repertoire. In this respect, the claim was validated using various tools such as the RNAfold server to determine the 2D structure, Barriers server to comprehend the RNA folding kinetics, RNAeval server to validate the siRNA-target interaction. It was found that the thermodynamics and kinetics repertoire of the siRNA are indeed rational and feasible. In this end, our computation approach has proven that our designed siRNA could interact with lincRNA-RoR/miR-145/ARF6 expression Pathway.
机译:寻找乳腺癌固化的研究目前正在进入基于转录组织的方法的有趣阶段。随着下一代测序(NGS)的应用,可以收集乳腺癌的分子信息。因此,在硅和湿实验室研究中,都确定了Lincrna-ROR / miR-145 / ARF6表达途径的作用不能被忽略作为三阴性乳腺癌(TNBC)的基本起始点之一。作为最具危险类型的乳腺癌,TNBC应得到治疗的是科学界可用的最先进的方法。生物信息学方法已经发现了TNBC可能的SiRNA候选药物候选者。发现干扰Lincrna-ROR和mRNA ARF6的siRNA可能是作为TNBC的药物候选者的可行机会。然而,这项索赔应该用更彻底的热力学和动力学计算方法验证,作为理解其分子曲目的综合方法。在这方面,使用诸如RNAfold服务器等各种工具来验证权利要求,以确定2D结构,屏障服务器理解RNA折叠动力学,RNAeval Server以验证siRNA-tarmation交互。结果发现,siRNA的热力学和动力学曲目确实是合理的,可行的。在此,我们的计算方法证明我们设计的siRNA可以与Lincrna-ROR / MIR-145 / ARF6表达途径相互作用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号